Gene polymorphisms of epidermal growth factor receptor and its downstream effector, interleukin-8, predict oxaliplatin efficacy in patients with advanced colorectal cancer.
about
Systemic therapies for pancreatic cancer--the role of pharmacogeneticsAllele Frequencies of the Epidermal Growth Factor Receptors Polymorphism R521K in Colorectal Cancer Patients and Healthy Subjects Indicate a Risk-Reducing Effect of K521 in Syrian PopulationDual blockade of epidermal growth factor receptor and insulin-like growth factor receptor-1 signaling in metastatic pancreatic cancer: phase Ib and randomized phase II trial of gemcitabine, erlotinib, and cixutumumab versus gemcitabine plus erlotiniExtraintestinal helminth infection reduces the development of colitis-associated tumorigenesis.Targeting IL-8 in colorectal cancer.Clinical, genetic, and pathological features of male pseudohermaphroditism in dog.Epidermal growth factor receptor pathway polymorphisms and the prognosis of hepatocellular carcinoma.Genetic variations in multiple drug action pathways and survival in advanced stage non-small cell lung cancer treated with chemotherapy.Interleukin genes and associations with colon and rectal cancer risk and overall survival.Pharmacogenomics of colorectal cancer prevention and treatment.A polymorphism of EGFR extracellular domain is associated with progression free-survival in metastatic colorectal cancer patients receiving cetuximab-based treatment.Epidermal growth factor receptor in pancreatic cancer.Pharmacogenetics in colorectal cancer: a systematic review.EGFR pathway polymorphisms and bladder cancer susceptibility and prognosis.Genetic polymorphisms in the EGFR (R521K) and estrogen receptor (T594T) genes, EGFR and ErbB-2 protein expression, and breast cancer risk in Tunisia.Polymorphisms in VEGF and IL-8 predict tumor recurrence in stage III colon cancer.-251 T/A polymorphism of the interleukin-8 gene and cancer risk: a HuGE review and meta-analysis based on 42 case-control studies.Pharmacogenomics and metastatic colorectal cancer: current knowledge and perspectives.Interleukin-8 is associated with proliferation, migration, angiogenesis and chemosensitivity in vitro and in vivo in colon cancer cell line models.Interleukin-8 and its receptor CXCR2 in the tumour microenvironment promote colon cancer growth, progression and metastasis.FcγR and EGFR polymorphisms as predictive markers of cetuximab efficacy in metastatic colorectal cancer.Epidermal growth factor receptor R521K polymorphism shows favorable outcomes in KRAS wild-type colorectal cancer patients treated with cetuximab-based chemotherapy.Associations between genetic polymorphisms of epidermal growth factor receptor (EGFR) and survival of colorectal cancer (CRC) patients treated with 5-fluorouracil-based chemotherapy.Which is false: oxaliplatin or fluoropyrimidine? An analysis of patients with KRAS wild-type metastatic colorectal cancer treated with first-line epidermal growth factor receptor monoclonal antibody.The gene polymorphisms of IL-8(-251T/A) and IP-10(-1596C/T) are associated with susceptibility and progression of type 2 diabetic retinopathy in northern Chinese population.PI3K/PTEN/AKT/mTOR polymorphisms: association with clinical outcome in patients with head and neck squamous cell carcinoma receiving cetuximab-docetaxel.Polymorphism in epidermal growth factor receptor intron 1 predicts prognosis of patients with esophageal cancer after chemoradiation and surgery.A synonymous EGFR polymorphism predicting responsiveness to anti-EGFR therapy in metastatic colorectal cancer patients.
P2860
Q27021716-F7F9B607-2CE6-4B56-878F-E6AA8A946281Q28397131-35C15AB5-CA61-46B2-A76A-CB449639D4ABQ33416585-0A0DDD68-993D-4C96-B0C4-ED4F43240A73Q34157794-7F543C10-EFFD-4E0A-A505-86459218793EQ34267408-B558BE2D-7E50-4A44-988F-33C50FCBC446Q34564329-528E29BA-E664-409E-8047-1ACD8861DABBQ34991214-7BF55A7E-C519-4FF1-B775-04E2DFB65617Q35072797-B9455062-DD55-45D2-8031-45DD8723F866Q36315711-FD7DBF70-9DF8-4D49-A069-4C2743594F09Q36597059-0E7D6152-8BAB-4D74-86FE-C55BF44BF0E5Q36728796-24C5C150-D142-482B-BD7E-F320D59EF84AQ37132640-416B5BE5-25FD-4CDF-819B-747751E5D120Q37235638-7D4988C6-2D4B-4BAE-A39D-88EFE6B4ACBDQ37246657-E0300C81-E0EF-463A-8C78-4DCA1F35906CQ37264068-4138A40D-4865-413B-ADB5-76CF2D130612Q37326196-FB7FC4C3-CD47-4311-B566-6051AD27F35EQ37890906-743470E5-6A7E-4058-81D6-20123C421B51Q37969851-C26CCCE1-4AE7-4270-A4C3-98017924E997Q39677535-88751CD8-1AE4-4EA6-BD74-9054C5A800B2Q42181728-5C5A6953-A91E-48B1-8B92-40058DDEB37DQ42218820-FDDA2BD7-B0C9-413C-9222-2298993717B1Q44740671-2622A6E1-F105-44E7-8558-451290FC0537Q46105210-54BD8354-57BF-4799-9F82-FEF448CCD4FBQ46225923-5B8D438A-CA6B-4AC5-8F57-A635A979C066Q51276675-D376209D-6DBF-490B-A2B0-86CF346C9E88Q54227938-5BF93AA0-3CD9-41E9-B5F0-61C0A552A9C0Q54614965-395BF47E-3DE8-48D5-91DB-3FEDB58100BDQ55034379-C152577A-49FC-4CAA-AC8D-0700CF46687D
P2860
Gene polymorphisms of epidermal growth factor receptor and its downstream effector, interleukin-8, predict oxaliplatin efficacy in patients with advanced colorectal cancer.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh-hant
name
Gene polymorphisms of epiderma ...... th advanced colorectal cancer.
@en
Gene polymorphisms of epiderma ...... th advanced colorectal cancer.
@nl
type
label
Gene polymorphisms of epiderma ...... th advanced colorectal cancer.
@en
Gene polymorphisms of epiderma ...... th advanced colorectal cancer.
@nl
prefLabel
Gene polymorphisms of epiderma ...... th advanced colorectal cancer.
@en
Gene polymorphisms of epiderma ...... th advanced colorectal cancer.
@nl
P2093
P356
P1476
Gene polymorphisms of epiderma ...... th advanced colorectal cancer.
@en
P2093
David J Park
Denice D Tsao-Wei
Dongyun Yang
Erin Borchard
Jan Stoehlmacher
Katrin Rhodes
Michael Gordon
Oliver A Press
P304
P356
10.3816/CCC.2005.N.025
P407
P577
2005-07-01T00:00:00Z